1 tracked superinvestor hold Dbv Technologies S A Sponsored (DBVT), worth $8M combined, led by Stanley Druckenmiller. Smart money is accumulating DBVT as of the latest 13F filings.
Current price
$16.08
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also…
Market cap
$475M
P/E
-3.78
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$46
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$8M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating DBVT: 1 funds added or opened versus 0 trimming. 1 opened a brand-new position.
Dbv Technologies S A Sponsored (DBVT) is held by 1 tracked funds worth $8M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Stanley Druckenmiller at 0.2% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
This quarter 1 fund opened a brand-new position (Stanley Druckenmiller), with 0 adding and 0 trimming — a net accumulation signal.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| New buy | 0.2% | $8M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own DBVT?
1 tracked funds hold Dbv Technologies S A Sponsored (DBVT), the largest being Stanley Druckenmiller (Duquesne Family Office) at 0.2% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling DBVT?
In the most recent 13F quarter, 1 tracked fund added or opened DBVT and 0 trimmed it, including 1 brand-new position.
How much DBVT do tracked funds hold?
Combined disclosed long exposure to DBVT across tracked superinvestors is $8M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.